1. Home
  2. KSCP vs PRLD Comparison

KSCP vs PRLD Comparison

Compare KSCP & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$3.98

Market Cap

42.6M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$2.44

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
PRLD
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
69.1M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
KSCP
PRLD
Price
$3.98
$2.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$16.67
$4.00
AVG Volume (30 Days)
536.1K
428.1K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,610,000.00
$10,500,000.00
Revenue This Year
$9.63
N/A
Revenue Next Year
$31.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.50
250.00
52 Week Low
$2.45
$0.61
52 Week High
$17.79
$4.22

Technical Indicators

Market Signals
Indicator
KSCP
PRLD
Relative Strength Index (RSI) 41.52 68.38
Support Level $3.61 $1.90
Resistance Level $5.41 $2.38
Average True Range (ATR) 0.44 0.19
MACD -0.06 0.07
Stochastic Oscillator 23.14 96.12

Price Performance

Historical Comparison
KSCP
PRLD

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: